← Leaderboards
Sarah Elisabeth Sherr Leary
Seattle Children'S Hospital
$526,014
Attributed
$526,014
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $175.3K · FY2023–25$200K$150K$100K$50K$0
'23
'24
'25
Funding mix
By agency
NIH$526,014 · 1
By mechanism
R50$526,014 · 1
Top collaborators
No co-investigators on record.
Most similar at Seattle Children'S Hospital
Same institution · by research overlap
- James M Olson$23,190,448
- Christian Ludwig Roth$8,363,703
- M. Jennifer Abuzzahab$913,167
- Heather Leigh Herd Gustafson$2,399,099
- Danielle M Zerr$5,835,008
Others in their field
Other Rising Stars on “Acceleration”
- Angee Greer · Ppd Development Lp$82,531,927
- Julia Louise Moore Vogel · Scripps Research Institute, The$32,252,685
- Tim A Bertram · Wake Forest University School Of Medicine$30,163,580
- Nancy Jean Sullivan · Boston University Medical Campus$23,000,000
- Alanna Maguire · Mayo Clinic Rochester$16,353,346
- Michael Hogarth · University Of California, San Diego$15,375,743
Research focus
AccelerationGenomic DataAwardBiologicalBrainBrain NeoplasmsCancer EtiologyCentral Nervous SystemCentral Nervous System NeoplasmsChildChildhoodChildhood Brain NeoplasmChildhood Cancer MortalityClinical DataClinical ResearchClinical Trial ImplementationClinical TrialsClinical Trials NetworkData SharingEarly Phase Clinical TrialEnrollmentEquityFundingInfrastructure
Grant awards (3)
Pediatric brain tumors: Improving survival through integration of clinical molecular diagnostics and biologically targeted therapies into clinical trials$175,338
R50 · FY2025 · CA · contact PI
Pediatric brain tumors: Improving survival through integration of clinical molecular diagnostics and biologically targeted therapies into clinical trials$175,338
R50 · FY2024 · CA · contact PI
Pediatric brain tumors: Improving survival through integration of clinical molecular diagnostics and biologically targeted therapies into clinical trials$175,338
R50 · FY2023 · CA · contact PI